Vimarsana
Biggest News Aggregation in the World

Page 24 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Sclerosis Today - Breaking & Trending Today

Cumberland Pharmaceuticals : Moving Corporate Headquarters to Broadwest - Form 8-K - Vimarsana News

Cumberland Pharmaceuticals : Moving Corporate Headquarters to Broadwest - Form 8-K

Cumberland Pharmaceuticals Moving Corporate Headquarters to Broadwest NASHVILLE, Tennessee - Broadwest is pleased to announce it has entered into an agreement... | November 20, 2021

Cumberland Pharmaceuticals To Announce Third Quarter 2021 Financial Results - Vimarsana News

Cumberland Pharmaceuticals To Announce Third Quarter 2021 Financial Results

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2021 financial results and provide a Company...

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases - Vimarsana News

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

Diagnosed Prevalent Cases of Systemic Sclerosis to Rise by 2030 - Vimarsana News

Diagnosed Prevalent Cases of Systemic Sclerosis to Rise by 2030

Diagnosed prevalent cases of systemic sclerosis will reach 187,000 by 2030, forecasted by GlobalData

Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit - Vimarsana News

Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit

Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit USA - English Share this article Share this article TEL AVIV, Israel, May 12, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the company's CEO, Dr. Adi Mor will present a corporate update at Oppenheimer's virtual Rare and Orphan Disease Summit on May 21 st, 2021. Webcast link may be accessed here. The presentation will be availab...